Technologies that are the focus of extensive public debate prior to commercialization may have diffusion paths which are distinct from the classic sigmoid shape often used by economists. Descriptive and econometric analysis of ex ante and ex post data on bovine somatotropin use by Wisconsin dairy farmers reveal that this controversial technology has a relatively low adoption rate and little prospect for adoption growth in the near future. Further research on potential adoption outcomes for technologies that are politicized prior to commercialization could improve economists' predictive capacities.
No takes yet. Share an insight, caveat, or question.
Bradford L. Barham (1996) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: